First elected to the U.S. House of Representatives in 1994, Richard served five terms in the House and is currently serving North Carolina in his third term in the U.S. Senate. During his time in the House, he led legislation modernizing the U.S. Food and Drug Administration (FDA), and began his work to improve our nation’s biodefense and pandemic preparedness capabilities.

In the Senate, Richard serves as Ranking Member of the Health, Education, Labor, and Pensions Committee. Promoting innovation in America’s healthcare system has been a priority for him throughout his time in Congress. Richard has led on a number of significant legislative priorities, including the creation of today’s pandemic response framework through the passage and reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA), improving FDA’s ability to regulate cutting-edge treatments for patients, and consistently championing funding for medical innovation and research.